Sugi Predict

Sugi Predict / Compounds / SCHEMBL6086835

SCHEMBL6086835

SCHEMBL6086835

CN1CCN(CC(=O)OCCNc2ccc3c(c2)COC3=C2C(=O)Nc3ccccc32)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2D6 P10635 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ CHRM4 P08173 1/20 0.37
▸ CHRM5 P08912 1/20 0.37
▸ CHRM1 P11229 1/20 0.37
▸ CHRM3 P20309 1/20 0.37
▸ TSHR P16473 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ GMNN O75496 1/20 0.37
▸ APEX1 P27695 1/20 0.37
▸ FLT3 P36888 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ NTRK1 P04629 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086825 1.00 LMNA (0.37) LMNAALDH1A1CYP1A2CYP2D6USP2
SCHEMBL6088655 0.93 ALDH1A1 (0.38) ALDH1A1MAPTNTRK1CCNA2CDK2
SCHEMBL6088653 0.93 ALDH1A1 (0.38) ALDH1A1MAPTNTRK1CCNA2CDK2
SCHEMBL6086846 0.92 MEN1 (0.41) FLT3NTRK1CCNA2CDK2CCNA1
SCHEMBL6086841 0.92 MEN1 (0.41) FLT3NTRK1CCNA2CDK2CCNA1
SCHEMBL6086166 0.87 PDGFRB (0.39) LMNAALDH1A1CYP1A2CYP2D6USP2
SCHEMBL6086159 0.87 PDGFRB (0.39) LMNAALDH1A1CYP1A2CYP2D6USP2
SCHEMBL6087293 0.86 NTRK1 (0.38) LMNAALDH1A1USP2TSHRL3MBTL1
SCHEMBL6087297 0.86 NTRK1 (0.38) LMNAALDH1A1USP2TSHRL3MBTL1
SCHEMBL14725076 0.85 NTRK1 (0.33) MAPTNTRK1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490356-B1 (3Z)-3-(3-HYDRO-ISOBENZOFURAN-1-YLIDENE)-1,3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS ALLERGAN INC (US) 2013-02-27 — — EP disclosed
US-7060844-B2 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN, INC. (US) 2006-06-13 — — US disclosed
US-20060004084-A1 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN, INC. 2006-01-05 — — US disclosed
EP-1490356-A1 (3Z)-3-(3-HYDRO-ISOBENZOFURAN-1-YLIDENE)-1,3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS Allergan, Inc. (US) 2004-12-29 — — EP disclosed
US-20040019098-A1 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors ALLERGAN, INC. 2004-01-29 — — US disclosed
WO-2003084951-A1 (3Z) -3-(3-HYDRO-ISOBENZOFURAN-1-YLIDENE)-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS ALLERGAN, INC. (US) 2003-10-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004084-A1 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors CDK2, ERBB2, MAP3K3 LMNA 3833/4885ALDH1A1 1528/4885CYP1A2 2482/4885
US-20040019098-A1 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors CDK2, ERBB2, MAP3K3 LMNA 3822/4885ALDH1A1 1606/4885CYP1A2 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.